chr1-236717976-G-A
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_001103.4(ACTN2):c.241+4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000848 in 1,604,104 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001103.4 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACTN2 | NM_001103.4 | c.241+4G>A | splice_region_variant, intron_variant | ENST00000366578.6 | NP_001094.1 | |||
ACTN2 | NM_001278343.2 | c.241+4G>A | splice_region_variant, intron_variant | NP_001265272.1 | ||||
ACTN2 | NR_184402.1 | n.416+4G>A | splice_region_variant, intron_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152150Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000152 AC: 38AN: 249404Hom.: 0 AF XY: 0.000230 AC XY: 31AN XY: 134718
GnomAD4 exome AF: 0.0000889 AC: 129AN: 1451836Hom.: 0 Cov.: 28 AF XY: 0.000123 AC XY: 89AN XY: 722726
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152268Hom.: 1 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74450
ClinVar
Submissions by phenotype
Primary familial hypertrophic cardiomyopathy;C2677338:Dilated cardiomyopathy 1AA Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 09, 2023 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 15, 2021 | - - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 27, 2020 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at